Delivery Order SPE2DB22D3016-SPE2DB26FAAC5
Award Date 10/17/25
Potential Completion Date 10/20/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Levothyroxine Sodium, a thyroid hormone replacement medication. This firm fixed-price delivery order, valued at $9,454.63, is scheduled for completion by October 3, 2025, with fulfillment based at the contractor's Conshohocken, Pennsylvania facility. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 30, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $1,723.68 with an ultimate completion date of September 2, 2025, represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,485.56 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 25 MCG tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with no set-aside designation, issued competitively on September 25, 2025, with an ultimate completion date of September 26, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Levothyroxine Sodium, a thyroid hormone replacement medication, on September 12, 2025. This firm fixed-price delivery order, valued at $1,345.97, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The award was made on a...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone used to treat hypothyroidism and other thyroid conditions. This firm fixed price delivery order has a ceiling value of $1,801.64 and is scheduled for completion by October 20, 2025. The contract was awarded without a set-aside designation through competitive procurement, with performance taking place at...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,203,393 units of levothyroxine 100 mcg/5 ml in 5 ml vials. The completion date for this $3,662.25 contract is January 2, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous awards from DLA to supply pharmaceuticals, medical supplies, and distribution...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $536 to Amerisourcebergen Drug Corporation for the supply of 50 microgram levothyroxine capsules. As the prime contractor, Amerisourcebergen will deliver 30 capsules to an address in Conshohocken, Pennsylvania under a one day period of performance from July 19th to July 20th, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to...
- The federal contract award is for the delivery of 4,568,494,683 vials of Levothyroxine 500 mcg to the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price of $2,938.11 and an Ultimate Completion Date of June 10, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This delivery order is part of a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 microgram tablets of the drug levothyroxine. The contract has a ceiling value of $3,997.05 and runs through January 3, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Synthroid 50 MCG tablets (1,000-unit quantity) valued at $1,355.36. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...